These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 35908904)

  • 1. Inhibition of Spred/Sprouty Expression in the Skin of a Contact Dermatitis-Like Model.
    Sakai H; Sato K; Ito K; Kosugi I; Kiyama M; Kon R; Ikarashi N; Kamei J; Chiba Y; Hosoe T
    Biol Pharm Bull; 2022; 45(8):1208-1212. PubMed ID: 35908904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curcumin inhibits epigen and amphiregulin upregulated by 2,4,6-trinitrochlorobenzene associated with attenuation of skin swelling.
    Sakai H; Sato K; Sato F; Kai Y; Mandokoro K; Matsumoto K; Kato S; Yumoto T; Narita M; Chiba Y
    Inflamm Res; 2017 Aug; 66(8):663-678. PubMed ID: 28405735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Sprouty-related protein, Spred-1, localizes in a lipid raft/caveola and inhibits ERK activation in collaboration with caveolin-1.
    Nonami A; Taketomi T; Kimura A; Saeki K; Takaki H; Sanada T; Taniguchi K; Harada M; Kato R; Yoshimura A
    Genes Cells; 2005 Sep; 10(9):887-95. PubMed ID: 16115197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sprouty2 and Spred1-2 proteins inhibit the activation of the ERK pathway elicited by cyclopentenone prostanoids.
    García-Domínguez CA; Martínez N; Gragera T; Pérez-Rodríguez A; Retana D; León G; Sánchez A; Oliva JL; Pérez-Sala D; Rojas JM
    PLoS One; 2011 Feb; 6(2):e16787. PubMed ID: 21364986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct association of Sprouty-related protein with an EVH1 domain (SPRED) 1 or SPRED2 with DYRK1A modifies substrate/kinase interactions.
    Li D; Jackson RA; Yusoff P; Guy GR
    J Biol Chem; 2010 Nov; 285(46):35374-85. PubMed ID: 20736167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spred is a Sprouty-related suppressor of Ras signalling.
    Wakioka T; Sasaki A; Kato R; Shouda T; Matsumoto A; Miyoshi K; Tsuneoka M; Komiya S; Baron R; Yoshimura A
    Nature; 2001 Aug; 412(6847):647-51. PubMed ID: 11493923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sprouty-related Ena/vasodilator-stimulated phosphoprotein homology 1-domain-containing protein (SPRED1), a tyrosine-protein phosphatase non-receptor type 11 (SHP2) substrate in the Ras/extracellular signal-regulated kinase (ERK) pathway.
    Quintanar-Audelo M; Yusoff P; Sinniah S; Chandramouli S; Guy GR
    J Biol Chem; 2011 Jul; 286(26):23102-12. PubMed ID: 21531714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ELR
    Sakai H; Yabe S; Sato K; Kai Y; Sato F; Yumoto T; Inoue Y; Narita M; Matsumoto K; Kato S; Chiba Y
    Clin Exp Pharmacol Physiol; 2018 Jan; 45(1):27-33. PubMed ID: 28762515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spred-1 negatively regulates interleukin-3-mediated ERK/mitogen-activated protein (MAP) kinase activation in hematopoietic cells.
    Nonami A; Kato R; Taniguchi K; Yoshiga D; Taketomi T; Fukuyama S; Harada M; Sasaki A; Yoshimura A
    J Biol Chem; 2004 Dec; 279(50):52543-51. PubMed ID: 15465815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spred-2 deficiency exacerbates lipopolysaccharide-induced acute lung inflammation in mice.
    Xu Y; Ito T; Fushimi S; Takahashi S; Itakura J; Kimura R; Sato M; Mino M; Yoshimura A; Matsukawa A
    PLoS One; 2014; 9(9):e108914. PubMed ID: 25275324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tyrosines 303/343/353 within the Sprouty-related domain of Spred2 are essential for its interaction with p85 and inhibitory effect on Ras/ERK activation.
    Meng S; Zhang M; Pan W; Li Z; Anderson DH; Zhang S; Ge B; Wang C
    Int J Biochem Cell Biol; 2012 May; 44(5):748-58. PubMed ID: 22305891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress in experimental research on SPRED protein family.
    Gong J; Yan Z; Liu Q
    J Int Med Res; 2020 Aug; 48(8):300060520929170. PubMed ID: 32851895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Sprouty-related protein, Spred, inhibits cell motility, metastasis, and Rho-mediated actin reorganization.
    Miyoshi K; Wakioka T; Nishinakamura H; Kamio M; Yang L; Inoue M; Hasegawa M; Yonemitsu Y; Komiya S; Yoshimura A
    Oncogene; 2004 Jul; 23(33):5567-76. PubMed ID: 15184877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SPREDs (Sprouty related proteins with EVH1 domain) promote self-renewal and inhibit mesodermal differentiation in murine embryonic stem cells.
    Mühl B; Hägele J; Tasdogan A; Loula P; Schuh K; Bundschu K
    Dev Dyn; 2015 Apr; 244(4):591-606. PubMed ID: 25690936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spreds, inhibitors of the Ras/ERK signal transduction, are dysregulated in human hepatocellular carcinoma and linked to the malignant phenotype of tumors.
    Yoshida T; Hisamoto T; Akiba J; Koga H; Nakamura K; Tokunaga Y; Hanada S; Kumemura H; Maeyama M; Harada M; Ogata H; Yano H; Kojiro M; Ueno T; Yoshimura A; Sata M
    Oncogene; 2006 Oct; 25(45):6056-66. PubMed ID: 16652141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct requirements for the Sprouty domain for functional activity of Spred proteins.
    King JA; Straffon AF; D'Abaco GM; Poon CL; I ST; Smith CM; Buchert M; Corcoran NM; Hall NE; Callus BA; Sarcevic B; Martin D; Lock P; Hovens CM
    Biochem J; 2005 Jun; 388(Pt 2):445-54. PubMed ID: 15683364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Sprouty/Spred family as tumor suppressors: Coming of age.
    Kawazoe T; Taniguchi K
    Cancer Sci; 2019 May; 110(5):1525-1535. PubMed ID: 30874331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular cloning of mammalian Spred-3 which suppresses tyrosine kinase-mediated Erk activation.
    Kato R; Nonami A; Taketomi T; Wakioka T; Kuroiwa A; Matsuda Y; Yoshimura A
    Biochem Biophys Res Commun; 2003 Mar; 302(4):767-72. PubMed ID: 12646235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a dominant negative mutant of Sprouty that potentiates fibroblast growth factor- but not epidermal growth factor-induced ERK activation.
    Sasaki A; Taketomi T; Wakioka T; Kato R; Yoshimura A
    J Biol Chem; 2001 Sep; 276(39):36804-8. PubMed ID: 11495895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of SPRED2 (sprouty-related protein with EVH1 domain 2) as a negative regulator of the hypothalamic-pituitary-adrenal axis.
    Ullrich M; Bundschu K; Benz PM; Abesser M; Freudinger R; Fischer T; Ullrich J; Renné T; Walter U; Schuh K
    J Biol Chem; 2011 Mar; 286(11):9477-88. PubMed ID: 21199868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.